3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Leiomyoma
2
cyclopia sequence
1
Vomiting
1
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pain
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Lung Neoplasms
1
Lower Urinary Tract Symptoms
1
Insulin Resistance
1
Infertility
1
Hyperandrogenism
1
Hot Flashes
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Diarrhea
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
thymoglobulin
1
satralizumab
1
rhoA GTP-Binding Protein
1
eculizumab
1
Sugars
1
Steroids
1
Prednisone
1
Methylprednisolone
1
Mesna
1
Immunoglobulins
1
Hizentra
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Cyclophosphamide
1
CK-2017357
1
Bortezomib
1
Amifampridine
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Myasthenia Gravis
×
Sugars
×
Clear all
NCT00995722
2017-06-02
EPITOME'
University of Miami
Phase 3
Terminated
11 enrolled
14 charts